LLY · News · 20260923N
Revenue Performance and Mix
ELI LILLY & Co · 2026-09-23 · Importance 64 · Surprise 56 · In source text
Eli Lilly reported a 47.7% increase in Q2 2026 revenue. The reported growth was associated with high demand for GLP-1 medicines. Foundayo and broader GLP-1 production capacity were identified as key commercial priorities supporting future product availability.
Key facts
- Eli Lilly reported a strong Q2 2026 revenue increase of 47.7%. source
- Ken Langone believes Eli Lilly (LLY) could reach a $2,000 share price within three to four years. source
- Ken Langone has held Eli Lilly stock for nearly five decades. source
- The stock has shown strong performance in the last year, despite a recent short-term dip. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Eli Lilly reported a strong Q2 2026 revenue increase of 47.7%. |